The World Health Organization (WHO) warned on Monday of the danger of buying overpriced vaccines from intermediaries, reminding those countries should buy vaccines certified by the WHO and make sure to identify the origin of the product.
"We have received concerns regarding other vaccines... with intermediates selling it (one vaccine) at a much higher price than what has been actually sold by the manufacturers," said Mariangela Batista Galvao Simao, WHO Assistant Director-General for Access to Medicines and Health Products, during a press conference.
The issue of the role of intermediates for buying vaccines was raised recently as a middleman, located in the United Arab Emirates, was caught selling Sputnik vaccines to Ghana and Pakistan at double the original price.
Simao said that countries should either buy directly from the manufacturer or "contact the manufacturer to make sure that the intermediate is legal."
"There is a lot of substandard and falsified COVID products being commercialized out there, so you need to know the provenance," she added.
Simao also said that it was important to vaccinate people with products "certified" by the WHO.
"The advice of the WHO is that the countries use vaccines that have received emergency listing," she said, referring to the Emergency Use Listing used by the organization to approve new vaccines.
So far, eight COVID-19 vaccines were approved by the WHO for emergency use, including two Chinese vaccines -- Sinopharm and Sinovac, both of which have been distributed in several countries across the world.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU